Potential use of plectranthus amboinicus in the treatment of rheumatoid arthritis

Evidence-based Complementary and Alternative Medicine

Volumn 7, Issue 1, 2010, Pages 115-120

  Chang, Jia Ming ^a   Cheng, Chun Ming ^a   Hung, Le Mei ^a   Chung, Yuh Shan ^a   Wu, Rey Yuh ^a  

^a DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

Author keywords

Arthritis; Collagen; Herbal medicine; Inflammation; Rheumatoid

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; COLLAGEN TYPE 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDOMETACIN; INTERLEUKIN 1BETA; PLANT EXTRACT; PLECTRANTHUS AMBOINICUS EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; NONHUMAN; PERITONEAL EXUDATE CELL; PLECTRANTHUS; PLECTRANTHUS AMBOINICUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RHEUMATOID ARTHRITIS;

EID: 77249138254     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem168     Document Type: Article

References (21)

1. Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother 2004;48:3498-3507
2. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, et al. ''Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994;37:681-686
3. Waller ES. Evaluation of new indomethacin dosage forms. Pharmacotherapy 1983;3:324-333
4. Goldenberg MM. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin Ther 1999;21:1497-513discussion 1427-1498.
5. Bertolini A, Ottani A, Sandrini M. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 2001;44:437-450
6. White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol 2007;99:91-98
7. Lukhoba CW, Simmonds MS, Paton AJ. Plectranthus: a review of ethnobotanical uses. J Ethnopharmacol 2006;103:1-24.
8. Vera R, Mondon JM, Pieribattesti JC. Chemical Composition of The Essential Oil and Aqueous Extract of Plectranthus amboinicus. Planta Med 1993;59:182-183
9. Harsha VH, Hebbar SS, Shripathi V, Hegde GR. Ethnomedicobotany of Uttara Kannada District in Karnataka, India-plants in treatment of skin diseases. J Ethnopharmacol 2003;84:37-40.
10. Chang SL, Chang YC, Yang CH, Hong HS. Allergic contact dermatitis to Plectranthus amboinicus masquerading as chronic leg ulcer. Contact Dermatitis 2005;53:356-357
11. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990;118:193-232.
12. Campo GM, Avenoso A, Campo S, Ferlazzo AM, Altavilla D, Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther 2003;5:R122-31.
13. Jonsson T, Arnason JA, Valdimarsson H. Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor. Rheumatol Int 1986;6:199-204.
14. Shou J, Bull CM, Li L, Qian HR, Wei T, Luo S, et al. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 2006;8:R28.
15. Mindrescu C, Thorbecke GJ, Klein MJ, Vilcek J, Wisniewski HG. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. Arthritis Rheum 2000;43:2668-2677
16. Patten C, Bush K, Rioja I, Morgan R, Wooley P, Trill J, et al. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology. Arthritis Rheum 2004;50:3334-3345
17. Vierboom MP, Zavodny PJ, Chou CC, Tagat JR, Pugliese-Sivo C, Strizki J, et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum 2005;52:627-636
18. Calabrese LH. Molecular differences in anticytokine therapies. Clin Exp Rheumatol 2003;21:241-248
19. Louie SG, Park B, Yoon H. Biological response modifiers in the management of rheumatoid arthritis. Am J Health Syst Pharm 2003;60:346-355
20. Lubeck DP. A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 2001;19:811-818
21. Mohamed AH, Salena BJ, Hunt RH. NSAID-induced gastroduodenal ulcers: exploring the silent dilemma. J Gastroenterol 1994;29 Suppl 7:34-38